<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61B1CB96-E4DF-4ED5-99DB-D1A4E5544340"><gtr:id>61B1CB96-E4DF-4ED5-99DB-D1A4E5544340</gtr:id><gtr:name>Oxford Instruments plc</gtr:name><gtr:address><gtr:line1>Tubney Woods</gtr:line1><gtr:postCode>OX13 5QX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6CF79BC8-9021-40D2-9BDE-54F9DC0FA29E"><gtr:id>6CF79BC8-9021-40D2-9BDE-54F9DC0FA29E</gtr:id><gtr:name>Pulseteq Ltd</gtr:name><gtr:address><gtr:line1>GABLE END , BEECHWAY</gtr:line1><gtr:city>GUILDFORD</gtr:city><gtr:postCode>GU1 2TA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8D55713A-87FD-4232-B50F-49BB01546C91"><gtr:id>8D55713A-87FD-4232-B50F-49BB01546C91</gtr:id><gtr:name>GE (General Electric Company)</gtr:name><gtr:address><gtr:line1>General Electric Company</gtr:line1><gtr:line2>3135 Easton Turnpike</gtr:line2><gtr:postCode>06828</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Physiology Anatomy and Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61B1CB96-E4DF-4ED5-99DB-D1A4E5544340"><gtr:id>61B1CB96-E4DF-4ED5-99DB-D1A4E5544340</gtr:id><gtr:name>Oxford Instruments plc</gtr:name><gtr:address><gtr:line1>Tubney Woods</gtr:line1><gtr:postCode>OX13 5QX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6CF79BC8-9021-40D2-9BDE-54F9DC0FA29E"><gtr:id>6CF79BC8-9021-40D2-9BDE-54F9DC0FA29E</gtr:id><gtr:name>Pulseteq Ltd</gtr:name><gtr:address><gtr:line1>GABLE END , BEECHWAY</gtr:line1><gtr:city>GUILDFORD</gtr:city><gtr:postCode>GU1 2TA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8D55713A-87FD-4232-B50F-49BB01546C91"><gtr:id>8D55713A-87FD-4232-B50F-49BB01546C91</gtr:id><gtr:name>GE (General Electric Company)</gtr:name><gtr:address><gtr:line1>General Electric Company</gtr:line1><gtr:line2>3135 Easton Turnpike</gtr:line2><gtr:postCode>06828</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A65FBC9-81CF-4919-94EB-746661B21EB9"><gtr:id>6A65FBC9-81CF-4919-94EB-746661B21EB9</gtr:id><gtr:firstName>Damian</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Tyler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601490"><gtr:id>07E46C37-D138-4A4F-A545-132BABF45395</gtr:id><gtr:title>Hyperpolarized Magnetic Resonance Spectroscopy for Metabolic Imaging of the Diseased Heart</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601490</gtr:grantReference><gtr:abstractText>There are about 1.8 million people in the UK with diabetes and 3 million cases are predicted by 2010. Diabetics are at high risk of heart disease because the way they make energy from foods, such as fats and sugars, is faulty. Understanding these faults is important to find new ways to treat people with diabetes.
Magnetic Resonance Imaging (MRI) is a method which can see inside living things and can help us to see how we change the food we eat into energy. The big problem with MRI is that the amount of signal we can see can be very small. In 2003, a new method of imaging which gives more signal in MRI was invented. This new method provides greater than 10,000 times more signal for a short period of time. This method is a tool which can help us answer our questions about why some people make energy from food in a faulty way.
Our aim is to develop this new method to help us understand how normal hearts work and what goes wrong in diabetic hearts.</gtr:abstractText><gtr:technicalSummary>Molecular imaging, in which imaging technology is coupled with molecular probes to detect disease-specific markers, will transform our approach to disease detection and treatment. Recently developed methods that can hyperpolarize molecular tracers [Dynamic Nuclear Polarization (DNP) technique] result in greater than 10,000 fold increases in the sensitivity of Magnetic Resonance Spectroscopy (MRS) for metabolic imaging. The aim of this project is to develop further this technique to study initial rates of metabolism in the healthy rat heart and in a model of type-1 diabetes. Primarily the rates of pyruvate metabolism through key metabolic enzymes, such as pyruvate dehydrogenase, in the normal heart will be made. Through technical developments, this project will also allow the study of other important metabolic molecules, such as acetate and alpha-ketogluterate. Understanding of initial metabolic rates of key molecules will provide insight into disease identification, progression and treatment that will provide new information to basic biochemical science. The techniques developed could eventually be transferred to the clinical environment.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>360980</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Instruments</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HyperSense Purchase</gtr:description><gtr:id>2470CA28-EE17-4F2C-9618-A1CC1BFFB384</gtr:id><gtr:impact>Publication 19329759</gtr:impact><gtr:outcomeId>A51AAEBD0ED-1</gtr:outcomeId><gtr:partnerContribution>Supply of HyperSense polarizer at a discounted rate</gtr:partnerContribution><gtr:piContribution>Consultancy on the development of the HyperSense system based on our user experience</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GE Healthcare</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of Hyperpolarized Magnetic Resonance Spectroscopy</gtr:description><gtr:id>50EED313-FDC8-4BDB-922B-AA269155F656</gtr:id><gtr:impact>Realization of Patent number PN07100 and publications 19329759, 19253408, 18689683 and Tyler et al (Appl. Magn. Reson. 2008 34, 523-531)</gtr:impact><gtr:outcomeId>48B71C9084C-1</gtr:outcomeId><gtr:partnerContribution>Loan of Prototype Hyperpolarizer system to enable research and supply of 13C labelled material and radical</gtr:partnerContribution><gtr:piContribution>Research into the application of hyperpolarization technology to cardiac metabolism</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AstraZeneca Studentship</gtr:description><gtr:id>3DDC1921-E927-4E00-99A4-82D2F22EAE0C</gtr:id><gtr:impact>Studentship will commence in October 2010 and so no outputs to report</gtr:impact><gtr:outcomeId>4DF478731E9-1</gtr:outcomeId><gtr:piContribution>Jointly supervised studentship to commence in October 2010 as part of the SABS-IDC industrial doctoral training program at the University of Oxford</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Instruments</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC CASE Studentship with Oxford Instruments</gtr:description><gtr:id>FA08DF7C-9A3A-4592-8786-501B861D674D</gtr:id><gtr:impact>Studentship has just started and so not outputs yet</gtr:impact><gtr:outcomeId>0C516F068A0-1</gtr:outcomeId><gtr:partnerContribution>Support and assistance in the maintenance and operation of our HyperSense hyperpolarizer</gtr:partnerContribution><gtr:piContribution>Joint supervision of a DPhil student in the development of new metabolic tracer molecules for hyperpolarization and use in the study of cardiac metabolism</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PulseTeq Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC CASE Studentship with PulseTeq</gtr:description><gtr:id>E4214EA5-2845-45FB-8E1E-B3B4B6E1F3B7</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>58c833f46ee272.86559305-1</gtr:outcomeId><gtr:partnerContribution>Joint Supervision of an MRC CASE Studentship</gtr:partnerContribution><gtr:piContribution>Joint Supervision of an MRC CASE Studentship</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BHF Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>832B6283-10D1-4779-A388-34B1A47446DF</gtr:id><gtr:impact>Hosted an open day for British Heart Foundation volunteers to explain the research funded by their work

Have been invited to give a lecture at the regional BHF AGM on my research</gtr:impact><gtr:outcomeId>69156D7DB2D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Local Group AGM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>85BD3542-D08F-4238-BC3E-0A3306DCBC22</gtr:id><gtr:impact>Delivered a talk to the local BHF fund raising organising committee at their AGM

None</gtr:impact><gtr:outcomeId>SPR2cPLrGNo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>61630</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A0A2AABC-1360-48EC-9581-EAAE7A6F5925</gtr:id><gtr:outcomeId>0FB18E6D54E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26510</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Value in People Award</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>11EF64B7-8591-4999-A860-FA07711AAE82</gtr:id><gtr:outcomeId>49E5D85DFFA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Henry Wellcome Postdoctoral Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3F40FB1B-0B34-4BCA-AD55-6D2DAD7680DC</gtr:id><gtr:outcomeId>C28042B379D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1830667</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/11/9/28921</gtr:fundingRef><gtr:id>FD800927-896B-455C-A2FE-D3FD9610CF74</gtr:id><gtr:outcomeId>JusqTZjbkae0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126461</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4ADC16D4-CCBD-4561-84F2-130955247B7C</gtr:id><gtr:outcomeId>1CE028EA4CE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>492461</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Intermediate Basic Science Research Fellowship</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/10/002/28078</gtr:fundingRef><gtr:id>DD8EA342-4387-4F23-8D7D-BD9024E9C4D4</gtr:id><gtr:outcomeId>F3xZmZoG72Z0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14841</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Value In People Award</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>556F7441-3B18-4BB2-B46F-91795A29BCF9</gtr:id><gtr:outcomeId>WKoYHHmr71g0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>254587</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Immediate Postdoctoral Fellowship</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/16/7/31843</gtr:fundingRef><gtr:id>55C70631-6C12-4FCE-B55B-278F9F8E6352</gtr:id><gtr:outcomeId>56d7191616f219.35645257</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>998797</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Senior Basic Science Research Fellowship</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/14/17/30634</gtr:fundingRef><gtr:id>568057CD-D00E-4A1D-B708-5DC9BA53FD53</gtr:id><gtr:outcomeId>5461140cf1d977.53521182</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1069138</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>DKK</gtr:currCode><gtr:currCountryCode>Denmark</gtr:currCountryCode><gtr:currLang>da_DK</gtr:currLang><gtr:description>Danish Strategic Funding Initiative</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Danish Council for Strategic Research (DSF)</gtr:fundingOrg><gtr:fundingRef>LIFE-DNP</gtr:fundingRef><gtr:id>D5B384B7-5D75-48C9-A448-F060AF0DF1A6</gtr:id><gtr:outcomeId>56d7180e646cd6.19549124</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>114031</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Industrial CASE Award</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P015794/1</gtr:fundingRef><gtr:id>CFF4655E-2A0B-45D9-9763-088B89160429</gtr:id><gtr:outcomeId>58c83336ddc5e8.39212793</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The invention relates to a method of determination of PDH activity by 13C-MR detection using an imaging medium which comprises hyperpolarised l3C-pyruvate and to imaging media for use in said method.</gtr:description><gtr:grantRef>G0601490</gtr:grantRef><gtr:id>7E0951CE-C902-47C0-9891-36076EC634A4</gtr:id><gtr:impact>None</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>DCE8CF1ED1A</gtr:outcomeId><gtr:patentId>MX2010002193</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>METHOD OF DETERMINATION OF PDH ACTIVITY AND IMAGING MEDIA FOR USE IN SAID METHOD</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Use of Hyperpolarized Pyruvate to assess the activity of the Pyruvate Dehydrogenase enzyme in vivo</gtr:description><gtr:id>92BF812A-D3BE-4A57-A20E-9FB0510A10EC</gtr:id><gtr:impact>Realization of Patent - PN07100</gtr:impact><gtr:outcomeId>2866AEB0E47</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Assessment of In Vivo PDH Activity</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E2FF8018-A675-4EB9-96C7-5A149EA5CCB8</gtr:id><gtr:title>Assessment of Metformin-Induced Changes in Cardiac and Hepatic Redox State Using Hyperpolarized[1-13C]Pyruvate.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65e2318bf64fd1c17f754e7e39d2e76f"><gtr:id>65e2318bf64fd1c17f754e7e39d2e76f</gtr:id><gtr:otherNames>Lewis AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58c6ec71c929b5.39733526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D732AEC-37DB-4298-9934-907DA5B2D500</gtr:id><gtr:title>Clinical implications of cardiac hyperpolarized magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2984f747f6a36c7c961e40adb053161"><gtr:id>b2984f747f6a36c7c961e40adb053161</gtr:id><gtr:otherNames>Rider OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6647</gtr:issn><gtr:outcomeId>pm_12464_24_24103786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3014C2E8-A7DD-4883-90F5-C9DEE74BBF1A</gtr:id><gtr:title>Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 T with 3D spectral-spatial EPI.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6bfd0ed4a952f1c7b513fa2fcdf290b"><gtr:id>d6bfd0ed4a952f1c7b513fa2fcdf290b</gtr:id><gtr:otherNames>Miller JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>56d71467694291.01878988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEEB82B3-BE4F-4E1B-8276-214FDDF4A0EB</gtr:id><gtr:title>Hyperpolarized [1,4-C]Fumarate Enables Magnetic Resonance-Based Imaging of Myocardial Necrosis.</gtr:title><gtr:parentPublicationTitle>JACC. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6bfd0ed4a952f1c7b513fa2fcdf290b"><gtr:id>d6bfd0ed4a952f1c7b513fa2fcdf290b</gtr:id><gtr:otherNames>Miller JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1876-7591</gtr:issn><gtr:outcomeId>5a6f2c938ccf97.64228007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0353070F-2D8E-4D2C-803A-6FAD6931BFD5</gtr:id><gtr:title>Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebeb0525ece518499e9879f62c48bd7f"><gtr:id>ebeb0525ece518499e9879f62c48bd7f</gtr:id><gtr:otherNames>Bakermans AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_12464_24_24042017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>997DA6DE-0593-4DF6-A01F-50C6D577F6BA</gtr:id><gtr:title>Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/633861db28a2e01f0392c18c6910a461"><gtr:id>633861db28a2e01f0392c18c6910a461</gtr:id><gtr:otherNames>Atherton HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>rLWADYDyCyo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBEDE1A0-9209-4B92-AB7D-889BCBDD4702</gtr:id><gtr:title>Cardiac perfusion imaging using hyperpolarized (13)C urea using flow sensitizing gradients.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7154ecae6a12862b5fa3d56b59da12be"><gtr:id>7154ecae6a12862b5fa3d56b59da12be</gtr:id><gtr:otherNames>Lau AZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>56d7146736d621.78735203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9735ADD-BB43-47CA-BB84-3DC829BC622F</gtr:id><gtr:title>Metabolic imaging of acute and chronic infarction in the perfused rat heart using hyperpolarised [1-13C]pyruvate.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caee6e3400f14c2a26211bcbecb7bbde"><gtr:id>caee6e3400f14c2a26211bcbecb7bbde</gtr:id><gtr:otherNames>Ball DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_12464_24_23775685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>863A43CE-7152-4619-BA22-BD42E77084E8</gtr:id><gtr:title>Science to Practice: Hyperpolarized Metabolic MR Imaging--The Light at the End of the Tunnel for Clinical (13)C MR Spectroscopy?</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb685337b4ccd1ee7d8a8c2a9924af06"><gtr:id>cb685337b4ccd1ee7d8a8c2a9924af06</gtr:id><gtr:otherNames>Tyler DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>56d71468660617.85441213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F0678F8-5E10-4768-8BAA-FC8525560FFE</gtr:id><gtr:title>Accelerated human cardiac diffusion tensor imaging using simultaneous multislice imaging.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7154ecae6a12862b5fa3d56b59da12be"><gtr:id>7154ecae6a12862b5fa3d56b59da12be</gtr:id><gtr:otherNames>Lau AZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>546110a9c60150.05609151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CDE4501-54A4-435F-B9FA-7981D35C83F4</gtr:id><gtr:title>The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>0BBAA690827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2751B6F9-2D1C-4B99-B704-DF12D2C8E28D</gtr:id><gtr:title>Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12464_24_23431149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74273614-C2D2-455E-86DE-3F4CADCA59B3</gtr:id><gtr:title>In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>F114F2B70DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A448AF8-8A62-4D1D-AF2A-1B04F3590729</gtr:id><gtr:title>Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>dq4d6H5RxfQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BBD33B-35C6-4AE9-AC10-6A66497D3065</gtr:id><gtr:title>Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f67bc8dd07dcd23fe2f87307036edaf"><gtr:id>4f67bc8dd07dcd23fe2f87307036edaf</gtr:id><gtr:otherNames>Le Page LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>58c6ec71a70703.59792459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F228CA55-E80E-46C9-97AD-67BF1355E2E6</gtr:id><gtr:title>Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee305b12ca3112f382a7d704638034f9"><gtr:id>ee305b12ca3112f382a7d704638034f9</gtr:id><gtr:otherNames>Dodd MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>546110a9ee84a0.54814436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EA56007-16A1-4F5C-817C-C17B40DE873D</gtr:id><gtr:title>Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1-C]pyruvate andC-urea.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7154ecae6a12862b5fa3d56b59da12be"><gtr:id>7154ecae6a12862b5fa3d56b59da12be</gtr:id><gtr:otherNames>Lau AZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>56d7146834ae69.47705446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97AF7B26-CC7A-416E-8F0F-FDBE54E6A799</gtr:id><gtr:title>Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>1F3D7741DDA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DE26505-A617-4BB5-8992-5153FEF25BBE</gtr:id><gtr:title>Mapping of intracellular pH in the in vivo rodent heart using hyperpolarized [1-13C]pyruvate.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7154ecae6a12862b5fa3d56b59da12be"><gtr:id>7154ecae6a12862b5fa3d56b59da12be</gtr:id><gtr:otherNames>Lau AZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>58c6ec72c594b7.85097863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B148DEFC-3A17-43D5-9F47-010E06F2E605</gtr:id><gtr:title>Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f67bc8dd07dcd23fe2f87307036edaf"><gtr:id>4f67bc8dd07dcd23fe2f87307036edaf</gtr:id><gtr:otherNames>Le Page LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>56d71466c008d4.64025822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B0623F3-CF5D-400E-8F07-BD8751D6A41C</gtr:id><gtr:title>Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dd733f0def4a929f85c8de796bcc440"><gtr:id>5dd733f0def4a929f85c8de796bcc440</gtr:id><gtr:otherNames>Ashrafian H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>pm_12464_24_22405071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F02D15-00D4-4920-A55C-CD3599A512A5</gtr:id><gtr:title>Cardiovascular Applications of Hyperpolarized MRI.</gtr:title><gtr:parentPublicationTitle>Current cardiovascular imaging reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb685337b4ccd1ee7d8a8c2a9924af06"><gtr:id>cb685337b4ccd1ee7d8a8c2a9924af06</gtr:id><gtr:otherNames>Tyler DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1941-9074</gtr:issn><gtr:outcomeId>GJBtoGTBfgA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A690F19-CF5C-4918-B34C-AEC04102AED4</gtr:id><gtr:title>Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/633861db28a2e01f0392c18c6910a461"><gtr:id>633861db28a2e01f0392c18c6910a461</gtr:id><gtr:otherNames>Atherton HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>JK86EcdeYyL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC396A6-1E8D-4DF5-AF48-AE20CBF7166D</gtr:id><gtr:title>Application of Hyperpolarized Magnetic Resonance in the Study of Cardiac Metabolism</gtr:title><gtr:parentPublicationTitle>Applied Magnetic Resonance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ced69e7813dc8a7fd31f29c6624497b5"><gtr:id>ced69e7813dc8a7fd31f29c6624497b5</gtr:id><gtr:otherNames>Tyler D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>FAAA4C01BB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA5E868D-D5BD-4393-908E-019B31620CF8</gtr:id><gtr:title>Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>4091A26A074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FF2514F-88CA-45E9-AB69-AAFD3032A48F</gtr:id><gtr:title>Hyperpolarized butyrate: a metabolic probe of short chain fatty acid metabolism in the heart.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caee6e3400f14c2a26211bcbecb7bbde"><gtr:id>caee6e3400f14c2a26211bcbecb7bbde</gtr:id><gtr:otherNames>Ball DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>pm_12464_24_23798473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91CB6D5E-790A-4708-A880-FACE175D0426</gtr:id><gtr:title>Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Expert opinion on therapeutic targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65e2318bf64fd1c17f754e7e39d2e76f"><gtr:id>65e2318bf64fd1c17f754e7e39d2e76f</gtr:id><gtr:otherNames>Lewis AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-8222</gtr:issn><gtr:outcomeId>56d71467ec3698.40050825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8077738-ACED-4673-ADFE-0D0CAFD485C2</gtr:id><gtr:title>In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee305b12ca3112f382a7d704638034f9"><gtr:id>ee305b12ca3112f382a7d704638034f9</gtr:id><gtr:otherNames>Dodd MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_12464_24_22593200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79D67D51-43DF-4ECF-8D68-F1C06544CC62</gtr:id><gtr:title>Non-Invasive Immuno-Metabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65e2318bf64fd1c17f754e7e39d2e76f"><gtr:id>65e2318bf64fd1c17f754e7e39d2e76f</gtr:id><gtr:otherNames>Lewis AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>5aa25f3c0649a4.41192389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E70C71C-88BE-45A4-B9FF-778E1A1D74CF</gtr:id><gtr:title>In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47db6ab0e75733be1b0162b13fb01e0b"><gtr:id>47db6ab0e75733be1b0162b13fb01e0b</gtr:id><gtr:otherNames>Seymour AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>56d714667d5644.69401514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B0C2E81-793D-43F4-844D-D75A61411376</gtr:id><gtr:title>The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>pm_12464_24_22238215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17AE277-B5DA-4109-A2B9-01752A810631</gtr:id><gtr:title>Weighted averaging in spectroscopic studies improves statistical power.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6bfd0ed4a952f1c7b513fa2fcdf290b"><gtr:id>d6bfd0ed4a952f1c7b513fa2fcdf290b</gtr:id><gtr:otherNames>Miller JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>58c6ec717f3132.80850136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99C737B7-B774-4CBA-B1A3-33F8E97B4121</gtr:id><gtr:title>In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee305b12ca3112f382a7d704638034f9"><gtr:id>ee305b12ca3112f382a7d704638034f9</gtr:id><gtr:otherNames>Dodd MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6647</gtr:issn><gtr:outcomeId>pm_12464_24_23414451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E8731D-8EDF-42BA-BC89-530758F23403</gtr:id><gtr:title>Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>pm_12464_24_23258802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B39AC085-903A-4E88-8D7D-27BE06B0018F</gtr:id><gtr:title>Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54dce0975fdc4cedf1c8c352b2d554cc"><gtr:id>54dce0975fdc4cedf1c8c352b2d554cc</gtr:id><gtr:otherNames>Schroeder MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>ZE7yKPh8R6h</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601490</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>